Social determinants of health in studies assessing toxicities associated with immune checkpoint inhibitor treatment: A systematic review

被引：0
|
作者：
Georgopoulou, S. [1 ]
Jaganathan, P. P. [2 ]
Droney, J. M. [3 ]
Howell, P. [4 ]
Macklin-Doherty, A. [5 ]
Young, K. [6 ]
Cruickshank, S. [7 ]
机构：
[1] Royal Marsden Hosp Chelsea, Appl Hlth Res, London, England
[2] Chelsea & Westminster Hosp NHS Trust, Palliat Med, London, England
[3] Royal Marsden Hosp Chelsea, Symptom Control & Palliat Care Dept, London, England
[4] Royal Marsden Sch, London, England
[5] ICR Inst Canc Res, Lymphoma, London, England
[6] Royal Marsden Hosp Chelsea, Renal Melanoma Dept, London, England
[7] Royal Marsden Hosp Inst Canc Res, Appl Hlth Res, Chelsea, England
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1941
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1846P
引用
收藏
页码：S1089 / S1089
页数：1
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review
    Plazy, Caroline
    Hannani, Dalil
    Gobbini, Elisa
    CURRENT ONCOLOGY REPORTS, 2022, 24 (09) : 1095 - 1106
  • [22] The use of patient-reported outcome measures to assess toxicities and quality of life associated with immune checkpoint inhibitor therapy: A systematic review
    Jaganathan, P. P.
    Georgopoulou, S.
    Droney, J. M.
    Howell, P.
    Macklin-Doherty, A.
    Young, K.
    Cruickshank, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S1091 - S1091
  • [23] A SYSTEMATIC REVIEW OF THE DIAGNOSTIC CRITERIA, EFFICACY AND SAFETY OUTCOMES REPORTED IN STUDIES OF TREATMENT OF IMMUNE CHECKPOINT INHIBITOR COLITIS
    Ancha, Siri
    Alayo, Quazim A.
    Deepak, Parakkal
    Altayar, Osama
    GASTROENTEROLOGY, 2021, 160 (06) : S53 - S53
  • [24] Systematic review: disease activity indices for immune checkpoint inhibitor-associated enterocolitis
    Ma, Christopher
    MacDonald, John K.
    Nguyen, Tran M.
    Chang, Joshua
    Vande Casteele, Niels
    Feagan, Brian G.
    Jairath, Vipul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (02) : 178 - 190
  • [25] Immune checkpoint inhibitor induced lichenoid reactions: A systematic review of characteristics and treatment outcomes
    Abduelmula, Abrahim
    Awan, Ramsha
    Saif, Hammad
    Howard, Jessica
    JAAD INTERNATIONAL, 2022, 7 : 1 - 6
  • [26] Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities
    Wu, Nan-Chun
    Feng, Yin-Hsun
    Kuo, Yu Hsuan
    Chen, Wei-Yu
    Wu, Hong-Chang
    Huang, Chien-Tai
    Wang, Wen-Ching
    Kang, Nai-Wen
    Shih, Jhih-Yuan
    Chen, Zhih-Cherng
    Chang, Wei-Ting
    ACTA CARDIOLOGICA SINICA, 2022, 38 (01) : 39 - 46
  • [27] Treatment of Immune Checkpoint Inhibitor-associated Myocarditis
    Heemelaar, Julius C.
    Louisa, Maria
    Neilan, Tomas G.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (05) : 384 - 391
  • [28] Treatment of immune checkpoint inhibitor-associated arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (06): : E15 - E15
  • [29] MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR TOXICITIES: A REVIEW AND CLINICAL GUIDELINE FOR EMERGENCY PHYSICIANS
    Hryniewicki, Adam T.
    Wang, Claire
    Shatsky, Rebecca A.
    Coyne, Christopher J.
    JOURNAL OF EMERGENCY MEDICINE, 2018, 55 (04): : 489 - 502
  • [30] miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review
    Garcia-Gimenez, Jose Luis
    Saadi, Wiam
    Ortega, Angel L.
    Lahoz, Agustin
    Suay, Guillermo
    Carretero, Julian
    Pereda, Javier
    Fatmi, Ahlam
    Pallardo, Federico V.
    Mena-Molla, Salvador
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
12345